Why Pfizer’s stumble in the obesity market is a boon for Eli Lilly
Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain …
Novo Nordisk A/S
Pfizer to discontinue twice-daily version of weight loss pill
Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost weight but had trouble tolerating the …
Insurance companies will pay for weight-loss drugs for members
CNBC’s Jim Cramer on Monday emphasized his belief that GLP-1 drugs primarily used to treat diabetes and obesity and the companies that make them, like Eli Lilly and Novo Nordisk, …
Pfizer enters weight loss drug market with Novo Nordisk, Eli Lilly
CFOTO | Future Publishing | Getty Images As its Covid gains evaporate, Pfizer wants a chunk of the budding weight loss drug market. Analysts say upcoming data on Pfizer’s experimental …
AstraZeneca adds to obesity drug race, but Eli Lilly remains in lead
Eli Lilly (LLY) remains our favorite way to play the weight-loss drug market, despite a new entry this week from AstraZeneca (AZN). On Thursday, AstraZeneca said it paid $185 million …
CPI, retail earnings spotlight consumer spending
CNBC’s Jim Cramer on Friday laid out what to look for going into next week, highlighting earnings reports from several retail outfits as well as the latest consumer price index. …
Jim Cramer’s top 10 things to watch in the stock market Friday
My top 10 things to watch Friday, Nov. 10 1. U.S. stocks edge up in premarket trading Friday, with S & P 500 futures rising 0.43% at the end of …
Weight-loss drug Wegovy could get new FDA approval in six months
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Michael Siluk …
Eli Lilly diabetes drug Mounjaro supply improves in U.S.
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023. …
Pfizer (PFE) Q3 earnings report 2023
CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected loss for the third quarter as the drugmaker recorded charges largely related to struggles for …